§ Funding Round
Series B funding round for Prevail Therapeutics raising $50M in March 2019
Series B funding round for Prevail Therapeutics raising $50M in March 2019
| Investor | Firm Type | Partner |
|---|---|---|
InterWest | — | — |
| Organization | — | |
| Organization | — | |
Wildcat Ventures | — | — |
AbbVie Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
BVF Partners | — | — |
| Organization | — | |
Omega Funds | — | — |
Pontifax | — | — |
| Organization | — | |
Surveyor Capital | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$125M
Top Valuation
-
Prevail Therapeutics raised $50M in a Series B round.
The round was announced on 03/01/19.
